HPLC method for the concentration determination of ipriflavone and its seven metabolites in human plasma

Lévai, F; Szatmári, István

doi:10.1016/s0378-4274(96)80049-x

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ipriflavone was also determined by several techniques, in tablets by square-wave adsorptive cathodic stripping (SW-AdCS) voltammetry and LC- UV methods [ 23 ], in plasma by Liquid chromatography with mass detection [ 24 , 25 ], with its synthetic impurities by HPLC–PDA [ 26 ], HPLC -UV study of its pharmacokinetics and distribution in rabbits and human beings [ 27 – 30 ] and also in rat plasma, urine and tissue homogenate [ 31 ].…”

Section: Introductionmentioning

confidence: 99%

Development of chromatographic methods to determine multivitamins formulation depending on their solubility and polarity: comparative study using three greenness assessment tools

Galal,

Elzanfaly,

Hussien

et al. 2024

BMC Chemistry

View full text Add to dashboard Cite

High performance liquid chromatography is one of the techniques of choice for the separation and quantitative determination of drugs in mixture form. Ipriflavone, ascorbic acid, pyridoxine, vitamin D3, and lysine are formulated together as an adjuvant combination in osteoporosis. In this work, we developed and validated two complementary high performance liquid chromatographic methods to determine the five compounds in their pharmaceutical dosage form. The first method (method A) was capable of determining ipriflavone, ascorbic acid, pyridoxine, and vitamin D3 in their bulk and combined pharmaceutical formulation. The method is based on Liquid Chromatographic separation with UV detection at 254 nm using Agilent Eclipse XDB-C18 column with a mobile phase consisting of 25 mM ammonium acetate buffer (pH 4.2): methanol in gradient mode. Due to the high polarity of lysine, it was difficult to achieve satisfactory retention on reversed phase columns. So, we separated it on a strong cation exchange column (Exsil 100 SCX) without derivatization with a mobile phase consisting of 10 mM sodium dihydrogen phosphate and 200 mM sodium chloride (pH 6) with UV detection at 210 nm (method B). Validation of the proposed methods was performed according to ICH guidelines Q2(R1). The proposed methods proved to be valid for selective analysis of the stated drugs in their bulk and combined pharmaceutical formulation. Greenness assessment of the developed methods was evaluated using three assessment tools: ESA, GAPI and the most recently developed tool AGREE, showing a satisfactory comprehensive guide of the greenness of the developed methods.

show abstract